learn when to use non-vascular daignostic ultrasonic/ultrasound guidance for needle placment cpt code 76942 in percutaneous procedures.
In addition to SCLC, CPT-11 has been demonstrated to be active as single-agent chemotherapy for non-small-cell-lung-cancer, colon cancer, breast cancer, uterine cancer, stomach cancer, ovarian cancer, etc. DEVELOPMENT OF THE CPT-11 þ CDDP REGIMEN It is essential to combine the maximum ...
Trastuzumab resistance has been becoming a major obstacle for treatment of HER-2-positive breast cancer patients. Increasing evidence suggests that mesenchymal stem cells (MSCs) play critical roles during the formation of drug resistance, however, the underlying mechanism is not well known. In this ...